CXS
Click for more information
0.00% 70.0¢ chemgenex pharmaceuticals ltd

Ann: Omacetaxine European rights licensed to Hosp, page-7

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. Vayama
    9,286 Posts.
    clock Created with Sketch.
    14/12/09
    10:20
    Post #: 6039210
    re: Ann: Omacetaxine European rights licensed... Sounded OK. Not that I understand anything.

    The sellers were lining up this morning at around $110.

    Someone wants out and it capping this.
    CXS Price at posting: 99.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Canyon-1H well drilling advancing as planned, with promising results observed and key milestones on track for completion by late October
right-arrow Created with Sketch.
NEWS MOU executed with leading maritime partner to advance plans for a multi-user transhipping facility in West Pilbara
right-arrow Created with Sketch.
NEWS Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war
right-arrow Created with Sketch.
NEWS Form 20-F filed to explore U.S. market opportunities through proposed Nasdaq ADS listing, aligning with strategic global growth goals
right-arrow Created with Sketch.
NVU Nanoveu commences crucial benchmark testing for System-on-aChip (SoC) Semiconductor technology
right-arrow Created with Sketch.
NEWS The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CXS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.